LP
VOR icon

LMR Partners’s Vor Biopharma VOR Stock Holding History

LMR Partners’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,556
Closed -$56.7K – 1650
2024
Q4 		$56.7K Hold
2,556
– – ﹤0.01% 1031
2024
Q3 		$35.8K Hold
2,556
– – ﹤0.01% 1090
2024
Q2 		$51.1K Buy
2,556
+511
+25% +$16.5K ﹤0.01% 925
2024
Q1 		$96.9K Sell
2,045
-511
-20% -$22.4K ﹤0.01% 919
2023
Q4 		$115K Buy
2,556
+117
+5% +$4.83K ﹤0.01% 758
2023
Q3 		$103K Hold
2,439
– – ﹤0.01% 682
2023
Q2 		$151K Sell
2,439
-576
-19% -$52.6K ﹤0.01% 597
2023
Q1 		$324K Buy
3,015
+857
+40% +$95K 0.01% 787
2022
Q4 		$287K Buy
2,158
+820
+61% +$81.1K 0.01% 957
2022
Q3 		$107K Hold
1,338
– – ﹤0.01% 1047
2022
Q2 		$133K Buy
1,338
+338
+34% +$34.6K ﹤0.01% 1088
2022
Q1 		$121K Buy
+1,000
New +$170K ﹤0.01% 1174

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LMR Partners's VOR Position: Q1 2025 in Review

LMR Partners sold out of Vor Biopharma (VOR) in Q1 2025, closing a stake of 2,556 shares — an estimated $56.7K sold.

LMR Partners first reported a position in VOR in Q1 2022 and held it in 12 quarters. The position peaked at $324K in Q1 2023. 46 funds tracked by Wall St. Rank hold VOR as of Q1 2025.

  • LMR Partners reported no remaining Vor Biopharma position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 2,556 Vor Biopharma shares in Q1 2025, an estimated $56.7K.
  • LMR Partners first reported a position in Vor Biopharma in Q1 2022 and held it in 12 quarters.
  • LMR Partners's Vor Biopharma position peaked at $324K in Q1 2023.
  • 46 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.